A detailed history of American Century Companies Inc transactions in Glaukos Corp stock. As of the latest transaction made, American Century Companies Inc holds 2,562 shares of GKOS stock, worth $384,146. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,562
Previous 159,281 98.39%
Holding current value
$384,146
Previous $18.9 Million 98.23%
% of portfolio
0.0%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$113.62 - $135.39 $17.8 Million - $21.2 Million
-156,719 Reduced 98.39%
2,562 $333,000
Q2 2024

Aug 07, 2024

SELL
$89.48 - $118.35 $23.6 Million - $31.3 Million
-264,285 Reduced 62.4%
159,281 $18.9 Million
Q1 2024

May 14, 2024

SELL
$76.4 - $96.33 $47,520 - $59,917
-622 Reduced 0.15%
423,566 $39.9 Million
Q4 2023

Feb 13, 2024

BUY
$59.53 - $85.11 $25.3 Million - $36.1 Million
424,188 New
424,188 $33.7 Million
Q3 2023

Nov 13, 2023

SELL
$69.23 - $79.09 $506,694 - $578,859
-7,319 Reduced 1.07%
676,847 $50.9 Million
Q2 2023

Aug 14, 2023

BUY
$45.44 - $71.21 $30.8 Million - $48.2 Million
677,288 Added 9847.16%
684,166 $48.7 Million
Q1 2023

May 11, 2023

BUY
$43.88 - $52.48 $9,083 - $10,863
207 Added 3.1%
6,878 $344,000
Q4 2022

Feb 13, 2023

BUY
$40.82 - $57.75 $60,536 - $85,643
1,483 Added 28.59%
6,671 $291,000
Q3 2022

Nov 14, 2022

BUY
$46.84 - $58.49 $243,005 - $303,446
5,188 New
5,188 $276,000
Q4 2021

Feb 07, 2022

SELL
$40.27 - $56.99 $439,144 - $621,475
-10,905 Closed
0 $0
Q3 2021

Nov 10, 2021

BUY
$47.43 - $84.23 $253,703 - $450,546
5,349 Added 96.27%
10,905 $525,000
Q2 2021

Aug 05, 2021

BUY
$73.06 - $97.7 $405,921 - $542,821
5,556 New
5,556 $471,000

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $7.14B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track American Century Companies Inc Portfolio

Follow American Century Companies Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.